NYSE Earnings Report Database: Genworth Financial, InterMune, Pfizer, General Electric, EMC, and Abbott

HONG KONG, Jan. 17, 2013 /PRNewswire/ -- EarningForecast.com has issued consensus earnings forecast reports and equity research for the following companies: Genworth Financial (NYSE: GNW), InterMune (NASDAQ: ITMN), Pfizer (NYSE: PFE), General Electric (NYSE: GE), EMC (NYSE: EMC), and Abbott (NYSE: ABT).

(Logo: http://photos.prnewswire.com/prnh/20121030/HK02457LOGO )

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Genworth Financial Inc. (NYSE: GNW): On January 3, Genworth Financial Inc. (NYSE: GNW) recently announced the appointment of Michael Derstine as Chief Risk Officer for its Genworth U.S. Mortgage Insurance unit. Moreover, the company's Genworth Financial Wealth Management has named James Hanna as Chief Technology Officer and member of the Senior Leadership Team. Genworth Financial will post its fourth-quarter financial results on February 5, 2013. Do you think now is a good time to buy or sell the stock?

Read Full Report: http://www.earningforecast.com/PR/011713A/GNW/GenworthFinancial.pdf

InterMune, Inc. (NASDAQ: ITMN): Abnormal trading volume of InterMune, Inc. (NASDAQ: ITMN) was found on January 16 reaching 16.77 million shares, almost 14 times heavier than usual day trading. This is following the company's announcement of selling an aggregate of US$105,000,000 principal amount of its 2.50% convertible senior notes due 2017 and 13,500,000 shares of its common stock at a price to the public of US$9.90 per share in concurrent underwritten public offerings. Want to monitor this company on an on-going basis?

Read Full Report: http://www.earningforecast.com/PR/011713A/ITMN/InterMune.pdf

Pfizer Inc. (NYSE: PFE): Pfizer Inc. (NYSE: PFE) is considering purchasing India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of US$2 billion. Pfizer shares ended lower by 0.04% to US$26.61 on over 28.51 million shares, below its 30-day average volume of 30.00 million shares. Investors may want to find out where PFE will go from here. Observe comprehensive Pfizer earnings forecast report here.

Read Full Report: http://www.earningforecast.com/PR/011713A/PFE/Pfizer.pdf

Today EarningForecast.com also observed abnormal trade volume for the following companies; Check out the consensus earnings forecast reports below:

General Electric Company (NYSE: GE):

Read Full Report: http://www.earningforecast.com/PR/011713A/GE/GeneralElectric.pdf

EMC Corporation (NYSE: EMC):

Read Full Report: http://www.earningforecast.com/PR/011713A/EMC/EMC.pdf

Abbott Laboratories (NYSE: ABT):

Read Full Report: http://www.earningforecast.com/PR/011713A/ABT/Abbott.pdf

About EarningForecast.com:

EarningForecast.com focuses on tracking and monitoring company Earnings Data for top market movers in US stocks market. EarningForecast.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit: EarningForecast.com/disclaimers/index.php for details.

SOURCE EarningForecast.com



RELATED LINKS
http://www.earningforecast.com/index.php
http://www.earningforecast.com/News/news.php?newsID=1273
http://www.earningforecast.com/disclaimers/index.php

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.